Drugs / angiotensin-converting enzyme inhibitors
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000558 | Nov 1995 → Jun 2005 | coronary artery disorder, myocardial infarction, myocardial ischemia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | angiotensin-converting enzyme inhibitors | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000558 ↗ |
| Action | Inhibit | “the addition of the angiotensin-converting enzyme (ACE) inhibitor trandolapril is compared to standard therapy” NCT00000558 ↗ |